BRADİKANT 30 MG/3 ML SOLUTION FOR S.C. INJECTION IN PRE-FILLED SYRINGE

BRADİKANT 30 MG/3 ML SOLUTION FOR S.C. INJECTION IN PRE-FILLED SYRINGE
Product Description

BRADİKANT is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1- esterase-inhibitor deficiency. 

Polifarma

  • Country/Region:
    Türkiye
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Animal Health
Finished Formulation products Distributor/Buyer
Laboratory, Analytical, Biotechnology Equipment
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution
Specifications
  • CAS Registry Number
    23.05.2019-2019/268
  • Supplied from
    Türkiye

Polifarma

  • Country/Region:
    Türkiye
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Animal Health
Finished Formulation products Distributor/Buyer
Laboratory, Analytical, Biotechnology Equipment
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution

More Products from Polifarma (60)

Polifarma resources (2)